Clinical Trial Update: Validation of Oxygen Nanosensor in Mitochondrial Myopathy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is underway to validate an oxygen nanosensor for use in mitochondrial myopathies and related mitochondrial diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Diseases
• Mitochondrial Myopathies

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Mitochondrial Myopathies, Mitochondrial Diseases | Phase 1 | Status: RECRUITING